美国银行表示，生物技术公司赛默飞世尔科技周二完成对Clario Holdings的收购，这笔交易“进一步巩固”了其作为人工智能受益者的地位。
分析师迈克尔·雷辛重申对赛默飞世尔科技的“买入”评级，并维持700美元的目标价。这意味着较周二收盘价有42%的上涨空间。
这笔88.75亿美元的全现金交易意味着赛默飞世尔科技将整合Clario基于人工智能的数据采集技术，以加速药物审批所需的试验流程。雷辛写道：“收购Clario使赛默飞世尔科技成为与人工智能价值实现方向结构性契合的平台之一。”
“Clario的数字终端基础设施和精心整理的真实世界证据数据集，增强了赛默飞世尔科技捕捉人工智能驱动生产力提升的能力，使该公司在这场变革中占据了有利位置。”
责任编辑：张俊 SF065
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.